Journal Information
Vol. 36. Issue 6.
Pages 483 (June 2017)
Share
Share
Download PDF
More article options
Vol. 36. Issue 6.
Pages 483 (June 2017)
Letter to the Editor
Open Access
Reply to the Letter to the Editor: “Quinolone-induced hypersensitivity reactions and the Kounis syndrome”
Resposta à Carta ao Editor «Reações de hipersensibilidade induzidas por quinolona e a síndrome de Kounis»
Visits
3710
João Gonçalves Almeida
Serviço de Cardiologia, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
Related content
Rev Port Cardiol. 2017;36:481-210.1016/j.repce.2016.12.018
Ioanna Koniari, Nicholas G. Kounis, George Soufras, Grigorios Tsigkas, George Hahalis
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear editor,

We would like to thank Koniari et al.1 for the interest demonstrated in our manuscript. We have reported the case of an 85-year-old male who developed type 1 Kounis syndrome (coronary spasm) after administration of ciprofloxacin.2 The authors pointed out the potential role of the combined effect of the drugs the patient was taking (hydroxyzine and alprazolam). Indeed, they cited case reports of cutaneous manifestations of allergy to hydroxyzine and alprazolam. However, our patient was chronically medicated with both drugs and never developed any manifestation of allergic reaction to them. Therefore, we think that a possible synergistic effect is less likely. Also, the temporal association with the intravenous administration of ciprofloxacin, in a patient previously sensitized to quinolones, is highly suggestive of reaction to that drug. Nevertheless, we think this concept is very interesting and we thank the authors for mentioning the possibility, since clinicians should be aware that a mix of antigens can bring about an additive allergic reaction and even Kounis syndrome.

The reference to the potential adverse effect that administration of morphine could have had in our case was also relevant and important. True opioid allergies are rare and mediated by allergen-specific immunoglobulin E. Morphine causes a greater histamine release than hydromorphone and fentanyl.3 Therefore, as stated by the authors, in cases of suspected allergic reaction, morphine should not be the first-line opioid.

In conclusion, we think that Kounis syndrome is still an under-recognized entity and it is good to know that the medical community is gathering to standardize diagnostic and treatment criteria. Our group is interested and available to be part of the relevant scientific committee.

Conflicts of interest

The author has no conflicts of interest to declare.

References
[1]
I. Koniari, N.G. Kounis, G. Soufras, et al.
Quinolone-induced hypersensitivity reactions and the Kounis syndrome.
Rev Port Cardiol, 36 (2017), pp. 481-482
[2]
J. Almeida, S. Ferreira, J. Malheiro, et al.
A rare cause of acute coronary syndrome: Kounis syndrome.
Rev Port Cardiol, 35 (2016), pp. 699.e1-699.e4
[3]
R.G. Wahler Jr., D.B. Smith, K.B. Mulcahy.
Nebulized fentanyl for dyspnea in a hospice patient with true allergy to morphine and hydromorphone.
J Pain Palliat Care Pharmacother, 31 (2017), pp. 38-42
Copyright © 2017. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.